Pancreatogenic Diabetes Mellitus – Type 3c (T3cDM)

Authors

  • David Solil Internal/Gastroenterology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
  • Petr Dítě Internal/Gastroenterology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno; Medical Faculty Ostrava, Ostrava University, Ostrava, Czech Republic
  • Martina Bojková Internal Cardiology Clinic/Department of Gastroenterology, Faculty Hospital Ostrava, Ostrava, Czech Republic
  • Vladimir Kojecký Department of Internal Medicine, Tomas Bata Hospital Zlín, Zlín, Czech Republic
  • Jiří Dolina Internal/Gastroenterology Clinic, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
  • Bohuslav Kianička Second Department of Internal Medicine, St. Anne´s Faculty Hospital Brno and the Faculty of Medicine, Masaryk University, Brno, Czech Republic

DOI:

https://doi.org/10.15403/jgld-7071

Keywords:

diabetes mellitus, pancreatogenic diabetes, pancreatic cancer, chronic pancreatitis, acute pancreatitis, cystic fibrosis, hemochromatosis, exocrine pancreatic insufficiency

Abstract

Pancreatogenic diabetes mellitus (type 3c diabetes, T3cDM) is a distinct form of diabetes resulting from primary pancreatic disorders, most commonly chronic pancreatitis. It involves both - endocrine and exocrine dysfunction, leading to unstable glycemia with frequent hypo-and hyperglycemia. The condition is often underdiagnosed despite its notable prevalence in patients with pancreatic disease, including malignancy and post-surgical states. Clinically, it overlaps with type 1 and type 2 diabetes but is distinguished by malabsorption and weight loss. Diagnosis requires standard glycemic criteria alongside evidence of pancreatic pathology and exclusion of other diabetes types. Management combines lifestyle measures, pancreatic enzyme replacement, and primarily insulin therapy, with metformin in selected cases. Early recognition is crucial due to its association with pancreatic cancer and increased risk of microvascular complications.

Downloads

Published

2026-09-26

How to Cite

1.
Solil D, Dítě P, Bojková M, Kojecký V, Dolina J, Kianička B. Pancreatogenic Diabetes Mellitus – Type 3c (T3cDM). JGLD [Internet]. 2026 Sep. 26 [cited 2026 Oct. 9];35(3):318-22. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/7071

Issue

Section

Editorial